High-quality tools that deliver technical data, analytics and technology capabilities to help you to shorten the distance between discovery and impact
Watch videoElsevier's R&D Solutions are a portfolio of tools that bring together incomparable data assets, powerful analytics and technologies to help R&D professionals, engineers and researchers to invent and commercialise ideas, products and processes.
Make better pharmaceutical drug discovery and development decisions, from target identification through to pre-clinical and post-market surveillance.
Successfully develop, improve and commercialise compounds, while efficiently managing costs and achieving environment, health and safety (EHS) goals.
Stay ahead of the competition and at the forefront of technology, while managing costs, regulations and health and safety risks.
Empower students, faculties and researchers with data and technology to acquire essential skills and accomplish ground-breaking research.
"The hardest part in building our compound library was establishing the pipeline to extract, transform and load data from multiple sources, each with its own structure. Our biggest issue is cleaning up source data and this is no simple task. Things as simple as spelling mistakes can impair our pipeline." Dr. Jonny Wray, Head of Discovery Informatics at e-Therapeutics
"Having access to the full-text articles from all relevant disciplines in one place is very valuable and very efficient and ensures you are well aware of what your competition is doing." Roger Parker, Pre-Clinical Research Leader
Drug makers are turning their focus from developing blockbuster drugs to making advances in precision medicine treatments. But what will they need to do to succeed?
Embase increases the discovery of biomedical evidence to support critical life sciences functions, delivering relevant, up-to-date biomedical information to the global research community.
Geofacets is a geoscience technology solution that enables efficient and thorough analysis of subsurface geology to empower confident natural resource exploration decisions and research.
Knovel helps the chemical industry to tackle development and production challenges by providing visibility on substance suitability for specific applications and best practice data relevant to piping, chemical engineering and processing and EHS compliance.
Pathway Studio facilitates the interpretation of experimental data, giving greater insight into the mechanisms of disease and accelerating biological research.
PharmaPendium provides the comparative and up-to-date information needed to verify pharmacokinetic and experimental data, anticipate species-specific issues in translating in vitro and in vivo studies and predict potential drug–drug interactions and design clinical trial studies to comply with regulatory requirements.
QUOSA reduces time spent monitoring, managing, organising and annotating scientific and medical literature for triage and compliance reports such as PSURs and ICSRs.
Reaxys improves productivity, combining experimental chemical data and essential literature to return relevant extracted chemical data and citations in response to chemistry questions.
ScienceDirect, Elsevier’s leading information solution for researchers, enables pharmaceutical and life sciences researchers to more effectively and efficiently search authoritative, full-text scientific, technical and health content through the use of smart, intuitive functionality.
Scopus helps pharmaceutical and life sciences researchers to detect trends, find research partnerships and identify key opinion leaders with the world’s largest abstract and citation database of peer-reviewed literature, complete with tools to track, analyse and visualise scholarly research.
Elsevier.com visitor survey
We are always looking for ways to improve customer experience on Elsevier.com.
We would like to ask you for a moment of your time to fill in a short questionnaire, at the end of your visit.
If you decide to participate, a new browser tab will open so you can complete the survey after you have completed your visit to this website.
Thanks in advance for your time.